OncoCarta™ Panel v1.0
Rare Mutations Profiling in Cancer
Recent evidence has indicated that rare genetics variants may play a significant role in tumorigenesis, pathogenesis, and disease progression1. Genetic mutations resulting in the activation of oncogenes increase the probability that a normal cell will develop into a tumor cell. The frequency of oncogene mutations across human tumor types has been investigated in previous studies—30% of 1,000 tumor samples carried at least one mutation2, but further research can lead to oncogene mutation maps for specific tumor types, diseases, and/or individuals.
Until recently, profiling such genetic variants across many individuals with the necessary accuracy and coverage was not possible because either SNP arrays provide a whole-genome association view, or sequencing interrogates a specific region or locus. The Oncocarta™ Panel addresses these limitations, enabling investigation of over 230 mutations in parallel for fine mapping of single and co-occurring events across multiple samples.
The OncoCarta™ Panel v1.0 provides a highly sensitive group of assays for oncogene detection.
- Pre-designed assays for profiling multiple mutations in challenging genes such as EGFR, BRAF, KRAS, and KIT , eliminating any need for design optimization
- Thorough coverage with over 230 mutations across 19 oncogenes, providing an in depth look at the key mutations
- Ability to detect and quantify as low as 10% mutation frequency for low abundance events, enabling you to profile variants previously not possible with greater accuracy
PCR amplification and primer extension are performed using the OncoCarta™ Panel reagents to detect target molecules by MALDI-TOF mass spectrometry. Users run the entire panel consisting of 24 multiplexes per sample using a total of 480 ng. DNA from either cells, fresh, frozen or paraffin-embedded tissue. Following the sample run, you can detect and quantify mutation levels simultaneously across samples. Up to 32 samples (2 x 384-spot chips) can be processed in a single day, with time to analysis <1 hour using new enhanced Typer® software.
The OncoCarta™ Panel v1.0 kit components include reagents sufficient for processing 160 samples.
- PCR Reagents: 24 PCR Primer Mixes, PCR Reagent Set for amplification
- Extension Reagents: 24 PCR Extend Mixes, Extension Reagent Set
- SpectroCHIP® II and Clean Resin
- TyperAnalyzer software add-on
The OncoCarta™ Panel v1.0 is intended for research use only, and not for use in diagnostic procedures.
- Cosmic database
- Thomas et al, Nature Genetics, Volume 39, Number 3, March 2007
|